BioWorld Asia

Nov. 13, 2002

Partnerships Still Key Strategy For Biotech, Pharma Companies

STUTTGART, Germany - The eighth BIO-Europe 2002 International Partnering Conference drew approximately 1,200 representatives from all sectors of the biotechnology industry to Stuttgart to concentrate on partnering and making deals. (BioWorld International) Read More

New EuropaBio Leader Wants Backing For Biotech Research

Concealment Strategy Of Cancer Virus Could Point To Therapies

GW Releases Positive Phase III Results With Cannabis Drug

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

EU Launches Its New Research Program At 3-Day Conference

Biotech Investing Strategies Shift To Deal With Bear Market

Genome Campus At Science Park Finally Granted OK To Go Ahead

Genfit Enters Cardiovascular Deal With Japanese Company

Serono Acquires 92 Percent of Genset, Collaborates with IVAX

Other News to Note

Today's news in brief

BioWorld

BioWorld briefs for July 20, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

Capital remains selective in ‘barbell’ biotech market

BioWorld

Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...

Elderly hands holding broken brain structure

Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

BioWorld Science

Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...